Vaccine shows potential against cervical precancer, HPV infection

May 17, 2019
An investigational therapeutic vaccine eliminated high-grade cervical intraepithelial neoplasia and underlying HPV infection among one-third of women…

Single-dose pembrolizumab may induce remission in advanced melanoma

May 15, 2019
Patients with advanced melanoma appeared to experience durable remission with single-dose pembrolizumab initiated 3 weeks before surgery, according…

Researchers explore prostate cancer survivorship, cognitive effects of treatment

May 14, 2019
The University of Minnesota received $500,000 from the Th!nk Different Foundation to study survivorship among men with prostate cancer. The research…

CAR T cells show potential for treatment of pediatric solid tumors

May 13, 2019
Researchers at Stanford University School of Medicine have used chimeric antigen receptor T cells targeting B7-H3 to attack certain solid tumors in…

Combination therapy shows potential in TP53-mutated head and neck cancers

May 10, 2019
Yale Cancer Center researchers have identified a potential combination therapy that appears promising for patients with TP53-mutated head and neck…

Costs, lengths of stay after CAR T-cell therapy greater for younger patients

May 10, 2019
Two studies presented at this year’s Transplantation & Cellular Therapy Meetings provided new insights into treatment costs and hospital…
Molecular Oncology

Recent advances in pancreatic cancer: From screening protocols to precision medicine paradigms

HemOnc Today, May 10, 2019
Aatur D. Singhi, MD, PhD; Anirban Maitra, MBBS
Pancreatic ductal adenocarcinoma, or PDAC, is the third most common cause of cancer-related death in the United States, with a median 5-year survival…

Discovery of new leukemia subtypes may lead to targeted therapies, better outcomes

May 5, 2019
Researchers at St. Jude Children’s Research Hospital identified eight new subtypes of B-cell acute lymphoblastic leukemia, an advance that they…
Trend Watch

Medicare’s proposed CAR T reimbursement increase ‘woefully inadequate’

April 30, 2019
CMS has announced a proposed 15% increase in the amount it would reimburse hospitals for inpatient CAR T-cell therapy for Medicare patients. The…

Trial to assess novel therapeutic approach for kidney cancer

April 25, 2019
Researchers at Dana-Farber Cancer Institute are testing a new treatment strategy designed to improve outcomes for patients with kidney cancer at high…